CytomX Therapeutics Inc.
CTMX | NASDAQ
$2.79
+$0.03 (+1.09%)
Sep 22, 2026, 11:31 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 18.3M | 35.54M | 76.2M | 113.63M | 141.1M | 147.56M | 138.1M | 126.62M | 119.57M | 119.18M | 101.21M | 94.73M | 79.49M | 67.62M | 53.16M | 52.77M | 59.21M | 62.64M | 69.57M | 66.22M | 66.42M | 66.74M |
Cost of Revenue | 251K | 251K | n/a | n/a | n/a | n/a | n/a | n/a | 1.43M | 2.96M | 4.45M | 4.45M | 4.51M | 2.98M | 1.49M | 2.97M | 1.48M | 1.48M | 1.48M | n/a | n/a | n/a |
Gross Profit | 18.05M | 35.29M | 76.2M | 113.63M | 141.1M | 147.56M | 138.1M | 126.62M | 118.14M | 116.22M | 96.76M | 90.28M | 74.98M | 64.64M | 51.68M | 49.8M | 57.72M | 61.16M | 68.09M | 66.22M | 66.42M | 66.74M |
Operating Income | -87.15M | -64.66M | -22.37M | 23.25M | 43.13M | 35.96M | 25M | 6.71M | 13.69M | 18.8M | 1.49M | -7.42M | -48.22M | -74.93M | -101.33M | -118.13M | -111.06M | -100.22M | -83.78M | -72.25M | -64.51M | -61.44M |
Interest Income | 7.72M | 5.74M | 5.21M | 5M | 5.1M | 5.9M | 7.14M | 8.36M | 9.37M | 9.7M | 9.84M | 8.07M | 5.98M | 3.94M | 1.68M | 1.02M | 473K | 255K | 255K | 288K | 418K | 828K |
Pretax Income | -79.42M | -58.91M | -17.13M | 28.26M | 48.23M | 41.84M | 32.09M | 15.06M | 15.08M | 20.47M | 3.32M | -7.36M | -42.24M | -70.65M | -99.32M | -116.77M | -110.29M | -100.04M | -83.61M | -72.08M | -64.21M | -60.64M |
Net Income | -79.65M | -59.14M | -17.37M | 28.02M | 47.98M | 41.6M | 31.87M | 13.83M | 11.09M | 16.53M | -569K | -10.18M | -42.24M | -70.65M | -99.32M | -116.77M | -110.29M | -100.04M | -83.61M | -72.08M | -64.21M | -60.64M |
Selling & General & Admin | 32.08M | 31.1M | 29.84M | 28.1M | 29.63M | 31.4M | 29.73M | 31.93M | 27.41M | 25.46M | 24.74M | 24.58M | 30.74M | 36.05M | 39.55M | 40.49M | 41.99M | 39.63M | 38.32M | 38.85M | 36.4M | 35.69M |
Research & Development | 73.38M | 69.1M | 68.73M | 62.28M | 68.35M | 80.2M | 83.38M | 87.98M | 77.04M | 71.97M | 70.53M | 70.71M | 90.06M | 101.12M | 111.06M | 127.44M | 126.8M | 121.74M | 113.55M | 99.62M | 94.53M | 92.49M |
Other Expenses | -251K | -251K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.4M | 2.4M | 2.4M | 2.4M | -1 | -1 | -1 | n/a | n/a | -15K | -10K |
Operating Expenses | 105.2M | 99.95M | 98.57M | 90.39M | 97.98M | 111.6M | 113.11M | 119.91M | 104.45M | 97.42M | 95.27M | 97.69M | 123.2M | 139.57M | 153.01M | 167.93M | 168.79M | 161.37M | 151.87M | 138.47M | 130.93M | 128.18M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 105.46M | 100.2M | 98.57M | 90.39M | 97.98M | 111.6M | 113.11M | 119.91M | 105.88M | 100.38M | 99.73M | 102.15M | 127.71M | 142.55M | 154.5M | 170.9M | 170.27M | 162.86M | 153.35M | 138.47M | 130.93M | 128.18M |
Income Tax Expense | 231K | 234K | 237K | 245K | 248K | 236K | 223K | 1.23M | 3.99M | 3.94M | 3.89M | 2.82M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 218.94M | 177.27M | 170.19M | 165M | 129.08M | 87.12M | 80.1M | 85.09M | 84.88M | 82.03M | 67.31M | 80.73M | 66.54M | 66.25M | 66.23M | 65.91M | 65.54M | 65.39M | 65.21M | 64.53M | 65.06M | 60.97M |
Shares Outstanding (Diluted) | 218.94M | 177.27M | 170.19M | 165M | 129.08M | 87.15M | 80.1M | 85.2M | 84.88M | 82.63M | 67.31M | 80.99M | 66.54M | 66.25M | 66.23M | 65.91M | 65.54M | 65.39M | 65.21M | 65.21M | 65.06M | 60.97M |
EPS (Basic) | -0.45 | -0.36 | 0.01 | 0.42 | 0.58 | 0.50 | 0.40 | 0.17 | 0.14 | 0.20 | 0.02 | -0.39 | -0.77 | -1.11 | -1.46 | -1.46 | -1.47 | -1.41 | -1.31 | -1.23 | -1.20 | -1.24 |
EPS (Diluted) | -0.45 | -0.36 | 0.01 | 0.42 | 0.58 | 0.50 | 0.40 | 0.17 | 0.14 | 0.20 | 0.02 | -0.39 | -0.77 | -1.11 | -1.46 | -1.46 | -1.47 | -1.41 | -1.31 | -1.23 | -1.20 | -1.24 |
EBITDA | -78.23M | -57.67M | -15.76M | 29.54M | 49.81M | 43.53M | 33.86M | 16.9M | 17.92M | 24.39M | 8.26M | 4.47M | -30.35M | -59.68M | -89.24M | -112.59M | -106.91M | -96.59M | -80.17M | -69.54M | -61.88M | -58.83M |
EBIT | -79.42M | -58.91M | -17.13M | 28.26M | 48.23M | 41.84M | 32.09M | 15.06M | 15.08M | 20.47M | 3.32M | -591K | -35.47M | -63.88M | -92.55M | -116.77M | -110.29M | -100.04M | -83.68M | -72.23M | -64.54M | -61.44M |
Depreciation & Amortization | 1.19M | 1.24M | 1.38M | 1.28M | 1.57M | 1.69M | 1.77M | 1.84M | 2.84M | 3.91M | 4.94M | 5.06M | 5.12M | 4.2M | 3.3M | 4.18M | 3.37M | 3.44M | 3.51M | 2.69M | 2.67M | 2.61M |
Add to Watchlist
Select watchlists to add or remove CTMX